Tag: Vaccines
FDA Approves RSV Vaccine for Pregnant Women to Help Protect Newborns
Abrysvo indicated to be given between 32 and 36 weeks of pregnancy to prevent lower respiratory tract disease caused by RSV in infants from birth through 6 months
Better Responses Seen With Booster mRNA COVID-19 Vaccine in Pregnancy
Robust immune responses found after booster dose; efficient transplacental antibody transfer was seen
Education on Approval Process May Increase Acceptance of New RSV Vaccines
Those educated on vaccine approval process or about potential severity of RSV may be more accepting
Moderna COVID-19 Vaccine Tied to Lower Adverse Event Risk in Older Adults
mRNA-1273 vaccine also tied to greater protection against COVID-19 in older adults
CDC Recommends RSV Shot for All Infants
Vaccine has been shown to reduce the risk for both hospitalizations and health care visits for RSV in infants by about 80 percent
Nonpediatric Specialties Face Smaller Return Margins for HPV Vaccine Costs
Net returns from HPV vaccine cost reimbursements lowest for family physicians, highest for pediatricians
17.2 Percent of Children Start but Do Not Complete Seven-Vaccine Series
Associated factors include moving across state lines, number of children in household, lack of insurance coverage
Maternal Vaccine Can Prevent Group B Strep in Young Infants
GBS6 induced maternal antibody responses to all serotypes, with maternal-to-infant antibody ratios varying based on dose
CDC Gives Full Approval to RSV Vaccine for People Over 60
Agency added that it is advising seniors to first consult with their doctors to determine if the vaccine is right for them
CDC Panel Backs RSV Vaccine for Seniors
Panel called for 'shared clinical decision-making' between doctors and patients, stopped short of recommending that all seniors get the shots
